Alessandra Bertola
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis
Most-Cited Works
- Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.(2001)
- → Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma(2004)140 cited
- → Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome(2005)86 cited
- → Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma(2005)83 cited
- Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.(2002)
- → Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features(2003)64 cited
- → New drugs for treatment of multiple myeloma(2004)62 cited
- → Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency(2016)40 cited
- → Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant(2005)36 cited
- → Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m2)(2003)33 cited